A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials

DOI10.2307/2531495zbMath0715.62239OpenAlexW2088971961WikidataQ44153743 ScholiaQ44153743MaRDI QIDQ3201542

Peter F. Thall, Susan S. Ellenberg, Richard M. Simon

Publication date: 1989

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2531495

zbMATH Keywords

sample sizeclinical trialsleast favorable configurationearly terminationtwo- stage design

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items

A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard, One-Stage and Two-Stage Designs for Clinical Trials Using an Indifference-Zone Approach, Optimizing Sample Size Allocation and Power in a Bayesian Two-Stage Drop-the-Losers Design, Unnamed Item, A multi-armed Bayesian ordinal outcome utility-based sequential trial with a pairwise null clustering prior, Admissible and minimax estimation of the parameters of the selected normal population in two-stage adaptive designs under reflected normal loss function, On estimating the mean of the selected normal population in two-stage adaptive designs, Two-stage winner designs for non-inferiority trials with pre-specified non-inferiority margin, Estimation following selection of the largest of two normal means, A two-stage design for comparative clinical trials: the heteroscedastic solution, A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials, Discussion on “A Hybrid Selection and Testing Procedure with Curtailment in Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen, Discussion on “A Hybrid Selection and Testing Procedure with Curtailment” by Elena M. Buzaianu and Pinyuen Chen, A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard: The Case of Common, Known Variance, Parameter estimation following an adaptive treatment selection trial design, A review of phase 2-3 clinical trial designs, Point estimates and confidence regions for sequential trials involving selection, Bayesian approach to two-stage phase trial, Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications